Literature DB >> 3486097

Postoperative ST-segment elevation in coronary artery bypass surgery.

Z S Lockerman, D M Rose, J N Cunningham, E Lichstein.   

Abstract

Using Holter monitors, 50 patients were monitored for vasospasm following coronary artery bypass surgery. Transient 2 mm ST-segment elevation was considered to be diagnostic or coronary vasospasm. Four patients (8 percent) had evidence of coronary vasospasm. Over 30 variables, including preoperative demographic information and medication, intraoperative technique, and postoperative medication, were subjected to multiple stepwise regression analysis. This analysis failed to show any association between preoperative prophylaxis with either nifedipine or nitrates (or other variables) and the postoperative development of coronary vasospasm. We conclude that the incidence of coronary vasospasm is more common than previously thought, and that a nifedipine or nitrate withdrawal, in this study, was not associated with an increased incidence of postoperative coronary vasospasm.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3486097     DOI: 10.1378/chest.89.5.647

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  3 in total

1.  Native coronary artery and grafted artery spasm just after coronary artery bypass grafting: a case report.

Authors:  Jong Hyun Baek; Sung Sae Han; Dong Hyup Lee
Journal:  J Korean Med Sci       Date:  2010-03-19       Impact factor: 2.153

2.  Pharmacological activation of soluble guanylate cyclase improves vascular graft function.

Authors:  Gábor Veres; Yang Bai; Klára Aliz Stark; Harald Schmidt; Tamás Radovits; Sivakkanan Loganathan; Sevil Korkmaz-Icöz; Gábor Szabó
Journal:  Interact Cardiovasc Thorac Surg       Date:  2021-05-10

3.  Endothelial dysfunction of bypass graft: direct comparison of in vitro and in vivo models of ischemia-reperfusion injury.

Authors:  Gábor Veres; Péter Hegedűs; Enikő Barnucz; Raphael Zöller; Stephanie Klein; Harald Schmidt; Tamás Radovits; Sevil Korkmaz; Matthias Karck; Gábor Szabó
Journal:  PLoS One       Date:  2015-04-15       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.